Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Houston, Texas 77030


Purpose:

This pilot trial studies how well neurofeedback training works in decreasing acute radiotherapy-induced pain in patients with head and neck cancer. Neurofeedback training is a type of therapy that uses electroencephalograph and a computer software program to measure brain wave activity. Neurofeedback training may help teach patients ways to modify their own brain waves to decrease the perception of pain and improve quality of life.


Study summary:

PRIMARY OBJECTIVES: I. Determine the effects of an individualized LORETA (low resolution electromagnetic tomography) Z score neurofeedback program on changes in brain function using EEG (electroencephalography), qEEG (quantitative electroencephalography), and LORETA from immediately before to after each session in patients with head and neck cancer undergoing radiotherapy and experiencing pain. SECONDARY OBJECTIVES: I. Examine the effects of an individualized LORETA Z score neurofeedback program on perceptions of radiation-induced pain in head and neck cancer patients from immediately before neurofeedback training to immediately after neurofeedback training. II. Identify brain regions from qEEG and LORETA that are associated with a non-pain state and then an acute pain state. III. Examine the relationship between the patient and their spouse or primary caregiver. OUTLINE: Beginning at weeks 4 and 5 or 5 and 6 of radiotherapy, patients undergo neurofeedback training once per day (QID) three times per week (TIW) for up to 6 treatments. Patients also complete questionnaires over 10 minutes at baseline and after neurofeedback training. After completion of study, patients are followed up at 1 week.


Criteria:

Inclusion Criteria: - Patients must have the ability to understand and read English, sign a written informed consent, and be willing to follow protocol requirements - Patients must not have pain > 2 on a scale of 0 - 10 (self report) in the head and neck before starting radiotherapy - Scheduled to undergo a 6 week course of radiotherapy for head and neck cancer - No plans to change the type of pain medication during the course of the study Exclusion Criteria: - Patients who are taking any antipsychotic medications - Patients with active central nervous system (CNS) disease, such as clinically-evident metastases or leptomeningeal disease, dementia, or encephalopathy - Patients who have ever been diagnosed with bipolar disorder or schizophrenia - Patients with known, previously diagnosed head or neck pain from other pain syndromes or chronic pain requiring analgesics - Patients with a history of seizure disorders


NCT ID:

NCT02543320


Primary Contact:

Principal Investigator
Lorenzo Cohen
M.D. Anderson Cancer Center


Backup Contact:

N/A


Location Contact:

Houston, Texas 77030
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.